Haemonetics Corporation Restructuring Costs
Haemonetics Corporation (HAE) reported Restructuring Costs of -$3.52 million for the 3-month period ending 2024-12-28, per its 10-Q filed 2025-02-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2025-02-06
- Haemonetics Corporation restructuring costs for the quarter ending 2024-12-28 was -$3.52M.
- Haemonetics Corporation restructuring costs for the quarter ending 2024-09-28 was -$4.79M.
- Haemonetics Corporation restructuring costs for the quarter ending 2024-06-29 was -$4.62M, a 42118.18% decline year-over-year.
- Haemonetics Corporation restructuring costs for the quarter ending 2024-03-30 was $6.05M.
- Haemonetics Corporation restructuring costs for fiscal 2024 was $14.09M, a 2044.44% increase from fiscal 2023.
- Haemonetics Corporation restructuring costs for fiscal 2023 was $657.00K, a 84.47% decline from fiscal 2022.
- Haemonetics Corporation restructuring costs for fiscal 2022 was $4.23M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2024-12-28 | -$3.52M 10-Q · filed 2025-02-06 | -$8.31M derived: sum of 2 quarters · filed 2025-02-06 | $12.93M 10-Q · filed 2025-02-06 | -$6.88M derived: sum of 4 quarters · filed 2025-02-06 |
| 2024-09-28 | -$4.79M 10-Q · filed 2024-11-07 | $9.41M 10-Q · filed 2024-11-07 | -$3.37M derived: sum of 3 quarters · filed 2024-11-07 | -$11.34M derived: sum of 4 quarters · filed 2025-02-06 |
| 2024-06-29 | -$4.62M 10-Q · filed 2024-08-08 | $1.42M derived: sum of 2 quarters · filed 2024-08-08 | -$6.54M derived: sum of 3 quarters · filed 2025-02-06 | -$6.63M derived: sum of 4 quarters · filed 2025-02-06 |
| 2024-03-30 | $6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-20 | -$1.92M derived: sum of 2 quarters · filed 2025-02-06 | -$2.01M derived: sum of 3 quarters · filed 2025-02-06 | $14.09M 10-K · filed 2024-05-20 |
| 2023-12-30 | -$7.97M 10-Q · filed 2025-02-06 | -$8.05M derived: sum of 2 quarters · filed 2025-02-06 | $8.04M 10-Q · filed 2025-02-06 | |
| 2023-09-30 | -$86.00K 10-Q · filed 2024-11-07 | $75.00K 10-Q · filed 2024-11-07 | ||
| 2023-07-01 | $11.00K 10-Q · filed 2024-08-08 | |||
| 2023-04-01 | $657.00K 10-K · filed 2024-05-20 | |||
| 2022-12-31 | -$44.00K 10-Q · filed 2024-02-08 | -$209.00K derived: sum of 2 quarters · filed 2024-02-08 | -$165.00K derived: sum of 3 quarters · filed 2024-02-08 | |
| 2022-10-01 | -$165.00K 10-Q · filed 2023-11-02 | -$121.00K derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-07-02 | $44.00K 10-Q · filed 2023-08-08 | |||
| 2022-04-02 | $4.23M 10-K · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |